InvestorsHub Logo
Followers 4
Posts 316
Boards Moderated 0
Alias Born 11/09/2017

Re: None

Thursday, 01/06/2022 7:54:29 PM

Thursday, January 06, 2022 7:54:29 PM

Post# of 698817
I appreciate all the insight that this board gives but what we are up against does not bode well. I have a large position in this 100k shares and to me it’s big. I have serious concerns I need logic with. 1) 900 million share outstanding
2) all in the hands of retail 3) limited production capabilities 4) large debt and no reasonable cash on hand 4) I could go on but I don’t see how we could possibly survive. I don’t care if they cure cancer unless there’s a buyout I believe that after 30 years in biotech it adds up. DNDN and US Bioscience were in the same situation and if the longs on good news dump. Explain to me how even with a gap up on dramatic news how we could stop a collapse in price. I say on dramatic news $2 is the top from here. I know if and I mean if they could survive it could rise 2 years out. The cost in both time and money to market this would be well over $100 million and sad as it is their timing in this biotech crunch is pathetic. They took too long. I don’t see a way out as it stands now no matter how smart LO is unless she sacrifices shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News